DEA News
Return to News Home

Axios-Ipsos poll: Vaccine resistance grows

Percent who say they are likely to get the first generation COVID-19 vaccine as soon as it is available has fallen significantly.

Margaret Talev, Axios, Sep 22, 2020

The share of Americans eager to try a first-generation coronavirus vaccine dropped significantly in the latest installment of the Axios-Ipsos Coronavirus Index, as President Trump hyped suggestions that one could be ready before the election.

Why it matters: As the U.S. reaches a milestone of 200,000 deaths, this underscores the risks of politicizing the virus and its treatments.

The big picture: Americans don't see the vaccine as a silver bullet right now. Many respondents in Week 25 of our national survey feel it's risky and at least want to wait to see how others do. And only half are prepared to pay out of pocket for it.

By the numbers: Six in 10 Americans now say they don't want to take a COVID-19 vaccine as soon as it's available, up from 53% at the end of August.

Between the lines: 38% of respondents expect their health insurance to pay for them to get the vaccine if they decide to get one; 11% think the federal government will cover costs; and only 4% think they'll have to pick up the tab themselves.

What they're saying: Cliff Young, president of Ipsos U.S. Public Affairs, says growing concerns around the vaccine reflect a combination of scientists urging patience and the "political ping-pong" of President Trump's messaging and Democrats' pushback.

Methodology: This Axios/Ipsos Poll was conducted Sept. 18-21 by Ipsos' KnowledgePanel. This poll is based on a nationally representative probability sample of 1,008 general population adults age 18 or older.

Return to News Home